ESC 365 - Trimethylamine N-oxide as a Novel Biomarker for Left Ventricular Diastolic Dysfunction and Functional Remodeling in ST-Elevation Myocardial Infarction Patients.

ESC Professional Premium Access

Trimethylamine N-oxide as a Novel Biomarker for Left Ventricular Diastolic Dysfunction and Functional Remodeling in ST-Elevation Myocardial Infarction Patients.

Session: Multivessel disease in acute coronary syndromes

Topic: Biomarkers

Speaker: Doctor T. Tsai (Taipei, TW)

Event: ESC Congress 2024

Congress Presentation

Add to my library

About the speaker

Doctor Tsungying Tsai

Taipei (Taiwan)

0 follower

7 more presentations in this session

Complete revascularisation versus culprit lesion only PCI in patients with non-ST-elevation myocardial infarction and multivessel disease.

Speaker: Mr Y. Hung (Hong Kong, HK)

Virtual physiological analysis of non-culprit disease in patients with STEMI and multivessel disease: a substudy of the COMPLETE trial

Speaker: Doctor P. Morris (Sheffield, GB)

Complete vs culprit-lesion-only myocardial revascularization in patients with out-of-hospital cardiac arrest: insights from the multicentric "Lombardia CARe" registry

Speaker: Doctor L. Raone (Pavia, IT)

Impact of microvascular resistance reserve on post-STEMI cardiac remodelling and diastolic function

Speaker: Doctor T. Tsai (Taipei, TW)

Real-life impact of complete revascularization of non-ST elevation myocardial infarction during index hospitalization

Speaker: Doctor C. Carvalho (Vila Real, PT)

Access the full session

Multivessel disease in acute coronary syndromes

Speakers: Doctor T. Tsai, Mr Y. Hung, Doctor P. Morris, Doctor L. Raone, Doctor T. Tsai...

About the event

ESC Congress 2024

30 August - 2 September 2024

Sessions Presentations

Congress

ESC 365 is supported by

Explore sponsored resources

Explore sponsored resources